While JPMorgan acknowledges TEM’s unique diagnostics-data synergy, the analysts view the stock as fully valued after its recent rally, downgrading to Neutral and raising its December 2025 price target ...

ARK Invest's 2,300 BTC acquisition worth $196.26M signals rising institutional confidence, reinforcing Bitcoin’s growing role ...

Eric Lefkofsky, CEO and founder of Tempus AI, explains to Scottish Mortgage manager Tom Slater the huge potential in personalising cancer diagnosis and treatment at scale. Capital at risk.

Tempus AI (NASDAQ: TEM) is utilizing artificial intelligence to deliver better healthcare outcomes. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...

Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was up 12.7% on Wednesday after Needham & Company LLC raised their price target on the stock from $56.00 to $70.00. Needham & Company LLC currently has a ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

Nvidia Corp. (NASDAQ:NVDA) stock price was on a downtrend despite posting record revenues boosted by Blackwell AI GPU sales ...

Tempus AI (NASDAQ:TEM – Get Free Report) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating ...

Popular investor Cathie Wood and her Ark Invest funds took advantage of a buying opportunity on Tuesday by purchasing over 400,000 shares of ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI (NASDAQ:TEM) as the stock took a 15% ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...